Samples | Concentrations (μg/ml) | Percent inhibition (mean ± SEM) | IC50(μg/ml) |
---|---|---|---|
Ph.Cr | 1000 | 75.29 ± 0.64** | 285 |
500 | 64.72 ± 0.89*** | ||
250 | 47.44 ± 0.86*** | ||
125 | 42.78 ± 0.45*** | ||
Ph.Hex | 1000 | 90.30 ± 1.42 | 40 |
500 | 84.80 ± 0.41* | ||
250 | 69.51 ± 0.59*** | ||
125 | 65.90 ± 0.32*** | ||
Ph.Chf | 1000 | 85.94 ± 0.91* | 215 |
500 | 62.93 ± 1.73*** | ||
250 | 51.82 ± 0.95*** | ||
125 | 46.68 ± 0.22*** | ||
Ph.EtAc | 1000 | 81.01 ± 0.97** | 395 |
500 | 59.05 ± 1.03*** | ||
250 | 34.54 ± 0.60*** | ||
125 | 29.88 ± 0.89*** | ||
Ph.Bt | 1000 | 76.92 ± 1.15** | 415 |
500 | 58.89 ± 1.73*** | ||
250 | 21.65 ± 2.41*** | ||
125 | 18. 20 ± 0.47*** | ||
Ph.Aq | 1000 | 87.62 ± 1.42 | 3 |
500 | 84.79 ± 1.88 | ||
250 | 80.79 ± 1.08* | ||
125 | 75.12 ± 0. 54** | ||
Ph. Sp | 1000 | 76.32 ± 0.87** | 330 |
500 | 74.33 ± 0.66** | ||
250 | 35.40 ± 0.82*** | ||
125 | 30. 90 ± 0.45*** | ||
Galantamine | 1000 | 96.00 ± 0.30 | < 0.1 |
500 | 92.90 ± 0.60 | ||
250 | 89.45 ± 0.90 | ||
125 | 86.23 ± 0.22 |